A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia

NCT01435382 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Dyslipidemias
Hyperlipidemias
Lipid Metabolism Disorders
Metabolic Diseases

Interventions

BIOLOGICAL: PF-04950615 (RN316)
BIOLOGICAL: PF-04950615 (RN316)
BIOLOGICAL: PF-04950615 (RN316)
BIOLOGICAL: PF-04950615 (RN316)

Sponsor

Pfizer